These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16392817)

  • 1. Discovery of benzylidenebenzofuran-3(2H)-one (aurones) as inhibitors of tyrosinase derived from human melanocytes.
    Okombi S; Rival D; Bonnet S; Mariotte AM; Perrier E; Boumendjel A
    J Med Chem; 2006 Jan; 49(1):329-33. PubMed ID: 16392817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying melanogenesis inhibitors from Cinnamomum subavenium with in vitro and in vivo screening systems by targeting the human tyrosinase.
    Wang HM; Chen CY; Wen ZH
    Exp Dermatol; 2011 Mar; 20(3):242-8. PubMed ID: 21054558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of tyrosinase inhibition by deoxyArbutin and its second-generation derivatives.
    Chawla S; deLong MA; Visscher MO; Wickett RR; Manga P; Boissy RE
    Br J Dermatol; 2008 Dec; 159(6):1267-74. PubMed ID: 18811684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analogues of N-hydroxycinnamoylphenalkylamides as inhibitors of human melanocyte-tyrosinase.
    Okombi S; Rival D; Bonnet S; Mariotte AM; Perrier E; Boumendjel A
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2252-5. PubMed ID: 16442796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Versatile effects of aurone structure on mushroom tyrosinase activity.
    Dubois C; Haudecoeur R; Orio M; Belle C; Bochot C; Boumendjel A; Hardré R; Jamet H; Réglier M
    Chembiochem; 2012 Mar; 13(4):559-65. PubMed ID: 22307818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arbutin: mechanism of its depigmenting action in human melanocyte culture.
    Maeda K; Fukuda M
    J Pharmacol Exp Ther; 1996 Feb; 276(2):765-9. PubMed ID: 8632348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hypopigmentary action of KI-063 (a new tyrosinase inhibitor) combined with terrein.
    Kim DS; Lee S; Lee HK; Park SH; Ryoo IJ; Yoo ID; Kwon SB; Baek KJ; Na JI; Park KC
    J Pharm Pharmacol; 2008 Mar; 60(3):343-8. PubMed ID: 18284814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of the water-soluble polymer-wrapped derivative of fullerene on UVA-induced melanogenesis via downregulation of tyrosinase expression in human melanocytes and skin tissues.
    Xiao L; Matsubayashi K; Miwa N
    Arch Dermatol Res; 2007 Aug; 299(5-6):245-57. PubMed ID: 17333222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of binding-site homology between mushroom and bacterial tyrosinases by using aurones as effectors.
    Haudecoeur R; Gouron A; Dubois C; Jamet H; Lightbody M; Hardré R; Milet A; Bergantino E; Bubacco L; Belle C; Réglier M; Boumendjel A
    Chembiochem; 2014 Jun; 15(9):1325-33. PubMed ID: 24849818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chalcones as potent tyrosinase inhibitors: the importance of a 2,4-substituted resorcinol moiety.
    Khatib S; Nerya O; Musa R; Shmuel M; Tamir S; Vaya J
    Bioorg Med Chem; 2005 Jan; 13(2):433-41. PubMed ID: 15598564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid-phase synthesis of kojic acid-tripeptides and their tyrosinase inhibitory activity, storage stability, and toxicity.
    Kim H; Choi J; Cho JK; Kim SY; Lee YS
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2843-6. PubMed ID: 15125944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of Tribulus terrestris L decoction of different concentrations on tyrosinase activity and the proliferation of melanocytes].
    Deng Y; Yang L; An SL
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):1017-9. PubMed ID: 12433636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chalcones as potent tyrosinase inhibitors: the effect of hydroxyl positions and numbers.
    Nerya O; Musa R; Khatib S; Tamir S; Vaya J
    Phytochemistry; 2004 May; 65(10):1389-95. PubMed ID: 15231412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silymarin inhibits melanin synthesis in melanocyte cells.
    Choo SJ; Ryoo IJ; Kim YH; Xu GH; Kim WG; Kim KH; Moon SJ; Son ED; Bae K; Yoo ID
    J Pharm Pharmacol; 2009 May; 61(5):663-7. PubMed ID: 19406006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of 2',4',6'-trihydroxychalcones as a new class of tyrosinase inhibitors.
    Jun N; Hong G; Jun K
    Bioorg Med Chem; 2007 Mar; 15(6):2396-402. PubMed ID: 17267225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Benzylbenzamides: a new class of potent tyrosinase inhibitors.
    Cho SJ; Roh JS; Sun WS; Kim SH; Park KD
    Bioorg Med Chem Lett; 2006 May; 16(10):2682-4. PubMed ID: 16513349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of dihydropyrimidin-(2H)-one analogues and rhodanine derivatives as tyrosinase inhibitors.
    Liu J; Wu F; Chen L; Hu J; Zhao L; Chen C; Peng L
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2376-9. PubMed ID: 21411319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (-)-N-Formylanonaine from Michelia alba as a human tyrosinase inhibitor and antioxidant.
    Wang HM; Chen CY; Chen CY; Ho ML; Chou YT; Chang HC; Lee CH; Wang CZ; Chu IM
    Bioorg Med Chem; 2010 Jul; 18(14):5241-7. PubMed ID: 20584613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active constituents from Sophora japonica exhibiting cellular tyrosinase inhibition in human epidermal melanocytes.
    Lo YH; Lin RD; Lin YP; Liu YL; Lee MH
    J Ethnopharmacol; 2009 Jul; 124(3):625-9. PubMed ID: 19422905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetraketones: a new class of tyrosinase inhibitors.
    Khan KM; Maharvi GM; Khan MT; Jabbar Shaikh A; Perveen S; Begum S; Choudhary MI
    Bioorg Med Chem; 2006 Jan; 14(2):344-51. PubMed ID: 16198580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.